New York State Common Retirement Fund’s Fresh Tracks Therapeutics, Inc. Common Stock FRTX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q2
Sell
-647
Closed -$296K 3233
2018
Q1
$296K Hold
647
﹤0.01% 2586
2017
Q4
$373K Buy
647
+153
+31% +$101K ﹤0.01% 2486
2017
Q3
$373K Buy
494
+79
+19% +$62.5K ﹤0.01% 2504
2017
Q2
$354K Buy
415
+189
+84% +$138K ﹤0.01% 2578
2017
Q1
$159K Hold
226
﹤0.01% 2846
2016
Q4
$164K Hold
226
﹤0.01% 2842
2016
Q3
$216K Hold
226
﹤0.01% 2736
2016
Q2
$323K Hold
226
﹤0.01% 2488
2016
Q1
$278K Hold
226
﹤0.01% 2519
2015
Q4
$292K Hold
226
﹤0.01% 2573
2015
Q3
$327K Hold
226
﹤0.01% 2517
2015
Q2
$498K Buy
226
+10
+5% +$31.4K ﹤0.01% 2524
2015
Q1
$642K Buy
216
+21
+11% +$67.2K ﹤0.01% 1979
2014
Q4
$645K Buy
195
+21
+12% +$74.4K ﹤0.01% 1920
2014
Q3
$613K Hold
174
﹤0.01% 1951
2014
Q2
$668K Hold
174
﹤0.01% 1930
2014
Q1
$706K Sell
174
-52
-23% -$232K ﹤0.01% 1887
2013
Q4
$839K Buy
+226
New +$856K ﹤0.01% 1834

Other funds holding FRTX

New York State Common Retirement Fund's FRTX Position: Q2 2018 in Review

New York State Common Retirement Fund sold out of Fresh Tracks Therapeutics, Inc. Common Stock (FRTX) in Q2 2018, closing a stake of 647 shares — an estimated $296K sold.

New York State Common Retirement Fund first reported a position in FRTX in Q4 2013 and held it in 18 quarters. The position peaked at $839K in Q4 2013. 28 funds tracked by Wall St. Rank hold FRTX as of Q2 2018.

  • New York State Common Retirement Fund reported no remaining Fresh Tracks Therapeutics, Inc. Common Stock position as of Q2 2018 after selling out during the quarter.
  • New York State Common Retirement Fund sold 647 Fresh Tracks Therapeutics, Inc. Common Stock shares in Q2 2018, an estimated $296K.
  • New York State Common Retirement Fund first reported a position in Fresh Tracks Therapeutics, Inc. Common Stock in Q4 2013 and held it in 18 quarters.
  • New York State Common Retirement Fund's Fresh Tracks Therapeutics, Inc. Common Stock position peaked at $839K in Q4 2013.
  • 28 funds tracked by Wall St. Rank held Fresh Tracks Therapeutics, Inc. Common Stock as of Q2 2018.

Based on New York State Common Retirement Fund's 13F filing for Q2 2018, filed 10 Aug 2018.